NCT02354976 - A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

May 26, 2016

Study Completion Date

May 26, 2016

Conditions

Non-alcoholic Fatty Liver Disease (NAFLDHypertriglyceridemia

Interventions

DRUG

Placebo

Placebo matching to Omega-3 carboxylic acids (olive oil)

DRUG

Omega-3 carboxylic acid

4 g administered as 4 x 1 g capsules

DRUG

Fenofibrate 200mg

200mg capsule administered once daily

DRUG

Placebo

Placebo matching to fenofibrate 200mg

Trial Locations (4)

Research Site, Stockholm

Research Site, Uppsala

Research Site, Gothenburg

Research Site, Malmo